Fibromun

Unassigned

New Medicines

Advanced or metastatic soft tissue sarcoma - in combination with doxorubicin

Information

New molecular entity
Philogen
Philogen

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials
Yes
Yes

Category

A fully human recombinant fusion protein, consisting of recombinant antibody L19 with anti-tumour activity against extra domain B (ED-B) proteins, fused to human pro-inflammatory cytokine tumour necrosis factor alpha (TNFalpha).
Around 3,300 people were diagnosed with soft tissue sarcoma in 2010 in the UK [1].
Advanced or metastatic soft tissue sarcoma - in combination with doxorubicin
Intravenous infusion

Evidence based evaluations